Related Experiment Video
Updated: Aug 17, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
[Community-based MRSA. A new challenge for dermatology]
W Witte1, M Wiese-Posselt, U Jappe
1Bereich Wernigerode, Robert-Koch-Institut. wittew@rki.de
Abstract:
Treatment options for infections with MRSA are extremely limited because of resistance to all beta-lactam antibiotics and primarily because of the fast acquisition of further antibiotic resistance. During the past six years MRSA possessing the genomic determinant of an additional virulence factor emerged. This virulence factor, Panton-Valentine-Leukocidin, seems to be responsible for deep skin infections as well as necrotizing pneumonia. In order to avoid a continuous spread of MRSA, consequent prevention measures both in dermatological practices and for colonized patients in their general environment are essential.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) infections are difficult to treat due to antibiotic resistance. Emerging MRSA strains with Panton-Valentine-Leukocidin cause severe skin and lung infections, necessitating prevention strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Antibiotic Resistance
Context:
- Limited treatment options for Methicillin-resistant Staphylococcus aureus (MRSA) infections.
- Rapid acquisition of antibiotic resistance in MRSA strains.
- Emergence of MRSA with Panton-Valentine-Leukocidin (PVL) virulence factor in the last six years.
Purpose:
- To highlight the challenges in treating MRSA infections.
- To identify the role of PVL in severe MRSA infections.
- To emphasize the need for MRSA prevention measures.
Summary:
- MRSA infections present limited therapeutic choices due to resistance to beta-lactam antibiotics and rapid acquisition of further resistance.
- A specific MRSA strain carrying the Panton-Valentine-Leukocidin (PVL) virulence factor has emerged, contributing to severe skin infections and necrotizing pneumonia.
- Effective prevention strategies are crucial to curb the spread of MRSA in clinical settings and the community.
Impact:
- Increased understanding of MRSA virulence and resistance mechanisms.
- Recognition of PVL as a key factor in severe MRSA pathogenesis.
- Call for enhanced infection control and prevention protocols for MRSA.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
The Skin Microbiota
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Acne Infection